An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.


Other Article

Full Text

Duke Authors

Cited Authors

  • Parker, W; Berek, JS; Pritts, E; Olive, D; Kaunitz, AM; Chalas, E; Clarke-Pearson, D; Goff, B; Bristow, R; Taylor, HS; Farias-Eisner, R; Fader, AN; Maxwell, GL; Goodwin, SC; Love, S; Gibbons, WE; Foshag, LJ; Leppert, PC; Norsigian, J; Nager, CW; Johnson, T; Guzick, DS; As-Sanie, S; Paulson, RJ; Farquhar, C; Bradley, L; Scheib, SA; Bilchik, AJ; Rice, LW; Dionne, C; Jacoby, A; Ascher-Walsh, C; Kilpatrick, SJ; Adamson, GD; Siedhoff, M; Israel, R; Paraiso, MF; Frumovitz, MM; Lurain, JR; Al-Hendy, A; Benrubi, GI; Raman, SS; Kho, RM; Anderson, TL; Reynolds, RK; DeLancey, J

Published Date

  • March 2016

Published In

Volume / Issue

  • 23 / 3

Start / End Page

  • 303 - 308

PubMed ID

  • 26773577

Pubmed Central ID

  • 26773577

Electronic International Standard Serial Number (EISSN)

  • 1553-4669

Digital Object Identifier (DOI)

  • 10.1016/j.jmig.2015.12.012


  • eng

Conference Location

  • United States